Interphex USA 2010, the world's largest pharmaceutical, bio-pharmaceutical, health & personal care and fine chemical exhibition will be held at the Jacob K. Javits Convention Center in New York City, USA from April 20 to 22. This global marketplace will showcase the latest trends and technological advancements occurring across the pharmaceutical industry providing a perfect meeting place for both exhibitors and visitors.
Interphex which comprises four major segments: facilities, outsourcing & contract services, information technology, and manufacturing/processing, is regarded as the most trusted meeting place for leading-edge technology, education, products, services, capabilities and networking that drive scientific and process innovation in FDA regulated drug manufacturing - from development to market.
The four concurrent events offer education and technology for every phase of the drug development and manufacturing cycle.
This year a visitor will be able to experience a brand new Interphex, with a renewed focus on delivering results for both the pharmaceutical/biotechnology industry and for personal growth needs.. The 2010 Interphex will focus on will be featuring new companies,new capabilities and innovations,new products and services, new sustainable solutions, new signature series presentations, new events including a keynote address by MSNBC's Chris Matthews on "Healthcare Reform and Its Impact on the Biopharmaceutical Industry."
Interphex will provide industry professionals ample opportunity to network with colleagues, peers and suppliers throughout the event. It will enable them to meet their needs and solve their issues – increase productivity, increase product quality, maximize yields and efficiency, meet regulations or find sustainable solutions.
It will provide opportunities to interact with key buyers in the pharmaceutical and biopharmaceutical industry, gain direct access to the largest, most innovative drug and biopharmaceutical manufacturers.
It will enable industry professionals to meet decision-makers who seek new suppliers and solutions, meet partners who can provide instant access to cutting-edge technologies, meet qualified outsourcing partners and service providers.
It will help to find new, more cost-effective alternatives to existing processes and procedures,discover highly efficient new technologies that can significantly boost the productivity and see the most innovative new products from more than 1,000 exhibitors.
Thus professionals will find technology solutions and education for every aspect of drug manufacturing from process development through delivery to market.
The visitor's profile include CEOs & top executives, purchase executive, manufacturing engineers of pharmaceutical companies, R&D professionals, pharma machinery suppliers & distributors, pharma consultants, scientists and government experts .The exhibitors profile include suppliers of turnkey pharma plants, machinery & equipment for treatment of pharma raw materials, suppliers of turnkey pharma plants ,analytical instruments & lab reagents, testing instruments, microscopes, weighing machines, active pharma ingredients, tableting & capsulation unit, packaging materials, glassware, pharma publications, active pharma ingredients.
The Interphex brand has the highest quality standards of any pharmaceutical manufacturing event globally. Interphex events are organised in key pharmaceutical regions including the US, Puerto Rico, Mexico, Japan, China, Singapore, UK and Canada.
Interphex 2009
Over 12,000 pharmaceutical and biopharmaceutical manufacturing professionals had attended Interphex 2009 , which took place at the Jacob Javits Center in New York City from March 17-19
During the three-day event, industry professionals, representing 19 different countries could see products and equipment from over 900 life science manufacturers, suppliers and service providers.
The show was co-located with Biotechnica and The PharmaMedDevice Symposium. Highlights of the event included keynote addresses and other sessions concerning the current and future state of the industry. The opening keynote address was presented by Steven Burrill, CEO, Burrill & Company on "The Future of Pharmaceutical and Biopharmaceutical Manufacturing". His presentation was followed by a panel discussion with senior executives from Genentech, Eli Lilly & Co. and Wyeth Pharmaceuticals about how they are handling the major concerns affecting their organizations and what they envision for the future of pharmaceutical manufacturing.
A luncheon presentation on Single Use Technology co-sponsored by BioProcessing International and BioProcess Systems Alliance titled, "Single-Use Strategies in Bioprocessing: Reducing Cost, Time and Risk," featured a panel of users and suppliers.
Exhibitors included MG America, IMA North America, Thomas Engineering, Korsch America, Getinge, Bosch Packaging, Millipore, DSM Pharmaceuticals, GE Healthcare, Pall Life Sciences, Siemens Energy & Automation Advantapure, AES Clean Technologies and Saint Gobain.
Attendees included BMS, Genentech, Genzyme, ImClone, Johnson & Johnson, MassBiologics, Medimmune, Merck, Novartis, Pfizer, Purdue Pharma, Sanofi Pasteur, Schering-Plough, Teva and Wyeth.